Gastric & Breast Cancer e-journal
DOI: 10.2122/gbc.2012.0232
NEWS & VIEWS
|
Breast cancer advances in clinical cancer genome era: from conventional to integrative genome analysis. |
|
Affiliation: Head of the Breast Unit, Head of 1st Department of Propaedeutic Surgery, University of Athens, Greece.
Tel: +306932524836
E-mail: gzografo@med.uoa.gr |
Since there is no abstract available we provide the first paragraph.
Important advances have been made over the last two decades in translating robust conventional research into clinical practice. But it seems that chance for further substantial improvement in patients' oncological outcomes is now modest if we continue the same traditional strategy based single genes and proteins research. Moving from reductionist to network biology and from single gene sequencing to whole exome and whole genome sequencing and to integrative omics analysis we are now entering into the clinical cancer genome epoch.
(Citation: Gastric & Breast Cancer 2012; 11(3): 149-150)
|
|
| You can have an online full-text access and a PDF of this article: |
- Either purchase this paper for €35 EUR. Please, click here
|
|
- Or through one year subscription PayPal
|
|
